Oscar Health, Inc. (OSCR) experienced a significant intraday surge of 5.07% on Thursday, driven by positive analyst actions.
The stock's upward movement followed several analyst reports that raised price targets for the healthcare company. UBS increased its target price to $20 from $15 while maintaining a Neutral rating. Similarly, Barclays raised its target price to $21 from $18.
These upward revisions in price targets from major financial institutions contributed to increased investor confidence and buying activity during the trading session, resulting in the notable price appreciation for Oscar Health shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments